Table 2. Main results for meta-analysis between MDSC and clinicopathological factors.
| Characteristics | No. of studies | No. of patients | Pooled OR (95%CI) | P value |
|---|---|---|---|---|
| Gender (male vs. female) |
3 | 398 | 1.620 (0.980–2.678) | 0.060 |
| HBsAg/HBV/HCV (positive vs. negative) |
2 | 275 | 2.009 (0.951–4.245) | 0.067 |
| Tumor size (cm) (>5 vs. ≤5) |
1 | 183 | 0.651 (0.351–1.211) | 0.175 |
| Liver cirrhosis (yes vs. no) |
1 | 183 | 0.888 (0.473–1.666) | 0.712 |
| Number of tumors (multiple vs solitary) |
3 | 398 | 2.067 (0.785–5.441) | 0.141 |
| Tumor differentiation (poor/moderate vs. well) |
1 | 183 | 0.677 (0.375–1.225) | 0.197 |
| TNM stage (III/IV) vs. I/II) |
2 | 215 | 1.349 (0.073–24.994) | 0.841 |
| Child-Pugh score (B+C) vs. (0+A) |
3 | 398 | 0.823 (0.139–4.869) | 0.830 |
| Vascular invasion (yes vs. no) |
1 | 183 | 2.180 (1.154–4.118) | 0.016 |